A case of metaplastic carcinoma of the breast responsive to chemotherapy with ifosfamide and etoposide: Improved antitumor response by targeting sarcomatous features

Breast Journal

Volumn 16, Issue 6, 2010, Pages 663-665

  Brown Glaberman, Ursa ^a   Graham, Anna ^b   Stopeck, Alison ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; PACLITAXEL;

AGED; BREAST CARCINOMA; BREAST METAPLASTIC CARCINOMA; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOPENIA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LABORATORY TEST; LETTER; NEUROTOXICITY; PHYSICAL EXAMINATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; NEOPLASM METASTASIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78449287053     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.00975.x     Document Type: Letter

References (8)

1. Rosen PP,. Rosen's Breast Pathology, 2nd edn. Philadelphia: Lippincott Williams and Wilkins, 2001.
2. Rayson D, Adjei AA, Suman VJ, et al. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol 1999; 10: 413-9.
3. Gutman H, Pollock RE, Janjan NA,. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg 1995; 180: 193-9.
4. Pezzi CM, Patel-Parekh L, Cole K, et al. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the national cancer database. Ann Surg Oncol 2007; 14: 166-73.
5. Al Sayed AD, El Weshi AN, Tulbah AM, et al. Mataplastic carcinoma of the breast: Clinical presentation, treatment results and prognostic factors. Acta Oncol 2006; 45: 188-95.
6. Luni A, Aguilar M, Gatti G, et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007; 101: 349-53.
7. Confavreux C, Lurkin A, Mitton N, et al. Sarcomas and malignant phyllodes tumors of the breast - a retrospective study. Eur J Cancer 2006; 42: 2715-21.
8. Sorio R, Lombardi D, Spazzapan S, et al. Ifosfamide in advanced/disseminated breast cancer. Oncology 2003; 65 (Suppl 2): 55-8.